# Flowers Foods Inc: financial statements, quarterly

FLO · NYSE · CIK 1128928 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/flo.md) · [Financials](/companies/flo/financials.md) · [Filings](/companies/flo/filings.md) · [Insiders](/companies/flo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/flo/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2022 (2022-10-08) | Q4 FY2022 (2022-12-31) | Q2 FY2023 (2023-07-15) | Q3 FY2023 (2023-10-07) | Q4 FY2023 (2023-12-30) | Q2 FY2024 (2024-07-13) | Q3 FY2024 (2024-10-05) | Q4 FY2024 (2024-12-28) | Q2 FY2025 (2025-07-12) | Q3 FY2025 (2025-10-04) | Q4 FY2025 (2026-01-03) | Q2 FY2026 (2026-07-18) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,158](/filings/0000950170-23-062044.md) | [1,083 d](/filings/0000950170-25-022243.md) | [1,228](/filings/0000950170-24-097806.md) | [1,199](/filings/0000950170-24-123679.md) | [1,129 d](/filings/0001193125-26-071441.md) | [1,225](/filings/0001193125-25-181262.md) | [1,191](/filings/0001193125-25-269546.md) | [1,111 d](/filings/0001193125-26-071441.md) | [1,243](/filings/0001193125-26-359192.md) | [1,227](/filings/0001193125-25-269546.md) | [1,233 d](/filings/0001193125-26-071441.md) | [1,193](/filings/0001193125-26-359192.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [447](/filings/0000950170-23-062044.md) | [410 d](/filings/0000950170-25-022243.md) | [476](/filings/0000950170-24-097806.md) | [604](/filings/0000950170-24-123679.md) | [448 d](/filings/0001193125-26-071441.md) | [471](/filings/0001193125-25-181262.md) | [460](/filings/0001193125-25-269546.md) | [444 d](/filings/0001193125-26-071441.md) | [474](/filings/0001193125-26-359192.md) | [476](/filings/0001193125-25-269546.md) | [492 d](/filings/0001193125-26-071441.md) | [473](/filings/0001193125-26-359192.md) |
| Operating income | $m | [55.5](/filings/0000950170-23-062044.md) | [64.1 d](/filings/0000950170-25-022243.md) | [88.6](/filings/0000950170-24-097806.md) | [(59.3)](/filings/0000950170-24-123679.md) | [49.9 d](/filings/0001193125-26-071441.md) | [95.2](/filings/0001193125-25-181262.md) | [90.2](/filings/0001193125-25-269546.md) | [61.4 d](/filings/0001193125-26-071441.md) | [93.4](/filings/0001193125-26-359192.md) | [66.5](/filings/0001193125-25-269546.md) | [(71.1) d](/filings/0001193125-26-071441.md) | [68.1](/filings/0001193125-26-359192.md) |
| Interest expense | $m | [6.8](/filings/0000950170-23-062044.md) | [6.7 d](/filings/0000950170-25-022243.md) | [9.0](/filings/0000950170-24-097806.md) | [8.6](/filings/0000950170-24-123679.md) | [8.2 d](/filings/0001193125-26-071441.md) | [9.0](/filings/0001193125-25-181262.md) | [8.7](/filings/0001193125-25-269546.md) | [8.2 d](/filings/0001193125-26-071441.md) | [18.9](/filings/0001193125-26-359192.md) | [18.2](/filings/0001193125-25-269546.md) | [19.9 d](/filings/0001193125-26-071441.md) | [17.9](/filings/0001193125-26-359192.md) |
| Income tax | $m | [13.8](/filings/0000950170-23-062044.md) | [15.3 d](/filings/0000950170-25-022243.md) | [20.6](/filings/0000950170-24-097806.md) | [(16.6)](/filings/0000950170-24-123679.md) | [10.4 d](/filings/0001193125-26-071441.md) | [23.5](/filings/0001193125-25-181262.md) | [20.5](/filings/0001193125-25-269546.md) | [13.8 d](/filings/0001193125-26-071441.md) | [20.1](/filings/0001193125-26-359192.md) | [12.6](/filings/0001193125-25-269546.md) | [(19.7) d](/filings/0001193125-26-071441.md) | [13.6](/filings/0001193125-26-359192.md) |
| Net income | $m | [40.5](/filings/0000950170-23-062044.md) | [48.6 d](/filings/0000950170-25-022243.md) | [63.8](/filings/0000950170-24-097806.md) | [(46.7)](/filings/0000950170-24-123679.md) | [35.7 d](/filings/0001193125-26-071441.md) | [67.0](/filings/0001193125-25-181262.md) | [65.0](/filings/0001193125-25-269546.md) | [43.1 d](/filings/0001193125-26-071441.md) | [58.4](/filings/0001193125-26-359192.md) | [39.5](/filings/0001193125-25-269546.md) | [(67.1) d](/filings/0001193125-26-071441.md) | [40.7](/filings/0001193125-26-359192.md) |
| Diluted EPS | $ per share | [0.19](/filings/0000950170-23-062044.md) | not reported | [0.30](/filings/0000950170-24-097806.md) | [(0.22)](/filings/0000950170-24-123679.md) | not reported | [0.32](/filings/0001193125-25-181262.md) | [0.31](/filings/0001193125-25-269546.md) | not reported | [0.28](/filings/0001193125-26-359192.md) | [0.19](/filings/0001193125-25-269546.md) | not reported | [0.19](/filings/0001193125-26-359192.md) |
| Basic EPS | $ per share | [0.19](/filings/0000950170-23-062044.md) | not reported | [0.30](/filings/0000950170-24-097806.md) | [(0.22)](/filings/0000950170-24-123679.md) | not reported | [0.32](/filings/0001193125-25-181262.md) | [0.31](/filings/0001193125-25-269546.md) | not reported | [0.28](/filings/0001193125-26-359192.md) | [0.19](/filings/0001193125-25-269546.md) | not reported | [0.19](/filings/0001193125-26-359192.md) |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-07) | FY2023 (2023-12-30) | Q1 FY2024 (2024-04-20) | Q2 FY2024 (2024-07-13) | Q3 FY2024 (2024-10-05) | FY2024 (2024-12-28) | Q1 FY2025 (2025-04-19) | Q2 FY2025 (2025-07-12) | Q3 FY2025 (2025-10-04) | FY2025 (2026-01-03) | Q1 FY2026 (2026-04-25) | Q2 FY2026 (2026-07-18) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.6](/filings/0000950170-23-062044.md) | [22.5](/filings/0000950170-25-022243.md) | [15.8](/filings/0000950170-24-061086.md) | [6.9](/filings/0000950170-24-097806.md) | [15.0](/filings/0000950170-24-123679.md) | [5.0](/filings/0001193125-26-071441.md) | [7.3](/filings/0000950170-25-073101.md) | [11.0](/filings/0001193125-25-181262.md) | [16.7](/filings/0001193125-25-269546.md) | [12.1](/filings/0001193125-26-359192.md) | [11.5](/filings/0001193125-26-234437.md) | [52.8](/filings/0001193125-26-359192.md) |
| Current assets | $m | [715](/filings/0000950170-23-062044.md) | [688](/filings/0000950170-25-022243.md) | [688](/filings/0000950170-24-061086.md) | [703](/filings/0000950170-24-097806.md) | [708](/filings/0000950170-24-123679.md) | [656](/filings/0001193125-26-071441.md) | [715](/filings/0000950170-25-073101.md) | [741](/filings/0001193125-25-181262.md) | [752](/filings/0001193125-25-269546.md) | [729](/filings/0001193125-26-359192.md) | [762](/filings/0001193125-26-234437.md) | [786](/filings/0001193125-26-359192.md) |
| Total assets | $m | [3,435](/filings/0000950170-23-062044.md) | [3,427](/filings/0000950170-25-022243.md) | [3,429](/filings/0000950170-24-061086.md) | [3,428](/filings/0000950170-24-097806.md) | [3,430](/filings/0000950170-24-123679.md) | [3,400](/filings/0001193125-26-071441.md) | [4,327](/filings/0000950170-25-073101.md) | [4,345](/filings/0001193125-25-181262.md) | [4,350](/filings/0001193125-25-269546.md) | [4,184](/filings/0001193125-26-359192.md) | [4,181](/filings/0001193125-26-234437.md) | [4,186](/filings/0001193125-26-359192.md) |
| Current liabilities | $m | [670](/filings/0000950170-23-062044.md) | [659](/filings/0000950170-25-022243.md) | [622](/filings/0000950170-24-061086.md) | [589](/filings/0000950170-24-097806.md) | [569](/filings/0000950170-24-123679.md) | [549](/filings/0001193125-26-071441.md) | [569](/filings/0000950170-25-073101.md) | [589](/filings/0001193125-25-181262.md) | [958](/filings/0001193125-25-269546.md) | [976](/filings/0001193125-26-359192.md) | [988](/filings/0001193125-26-234437.md) | [1,018](/filings/0001193125-26-359192.md) |
| Long-term debt | $m | [1,038](/filings/0000950170-23-062044.md) | [1,048](/filings/0000950170-25-022243.md) | [1,044](/filings/0000950170-24-061086.md) | [1,069](/filings/0000950170-24-097806.md) | [1,054](/filings/0000950170-24-123679.md) | [1,022](/filings/0001193125-26-071441.md) | [1,790](/filings/0000950170-25-073101.md) | [1,749](/filings/0001193125-25-181262.md) | [1,380](/filings/0001193125-25-269546.md) | [1,356](/filings/0001193125-26-359192.md) | [1,324](/filings/0001193125-26-234437.md) | [1,286](/filings/0001193125-26-359192.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [399](/filings/0001193125-25-269546.md) | [400](/filings/0001193125-26-359192.md) | [400](/filings/0001193125-26-234437.md) | [400](/filings/0001193125-26-359192.md) |
| Shareholders' equity | $m | [1,375](/filings/0000950170-24-123679.md) | [1,352](/filings/0001193125-26-071441.md) | [1,376](/filings/0001193125-25-181262.md) | [1,384](/filings/0001193125-25-269546.md) | [1,407](/filings/0001193125-25-269546.md) | [1,410](/filings/0001193125-26-359192.md) | [1,416](/filings/0001193125-26-359192.md) | [1,428](/filings/0001193125-26-359192.md) | [1,420](/filings/0001193125-25-269546.md) | [1,303](/filings/0001193125-26-359192.md) | [1,302](/filings/0001193125-26-359192.md) | [1,324](/filings/0001193125-26-359192.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2020 (2020-10-03) | Q4 FY2020 (2021-01-02) | Q3 FY2021 (2021-10-09) | Q4 FY2021 (2022-01-01) | Q3 FY2022 (2022-10-08) | Q4 FY2022 (2022-12-31) | Q3 FY2023 (2023-10-07) | Q4 FY2023 (2023-12-30) | Q3 FY2024 (2024-10-05) | Q4 FY2024 (2024-12-28) | Q3 FY2025 (2025-10-04) | Q4 FY2025 (2026-01-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [88.6 d](/filings/0001564590-21-056408.md) | [90.0 d](/filings/0000950170-23-003619.md) | [91.8 d](/filings/0000950170-22-024470.md) | [29.4 d](/filings/0000950170-24-017647.md) | [108 d](/filings/0000950170-23-062044.md) | [69.4 d](/filings/0000950170-25-022243.md) | [128 d](/filings/0000950170-24-123679.md) | [92.0 d](/filings/0001193125-26-071441.md) | [114 d](/filings/0001193125-25-269546.md) | [130 d](/filings/0001193125-26-071441.md) | [54.4 d](/filings/0001193125-25-269546.md) | [125 d](/filings/0001193125-26-071441.md) |
| Capital expenditure | $m | [21.7 d](/filings/0001564590-21-056408.md) | [29.7 d](/filings/0000950170-23-003619.md) | [28.5 d](/filings/0000950170-22-024470.md) | [49.2 d](/filings/0000950170-24-017647.md) | [30.5 d](/filings/0000950170-23-062044.md) | [40.7 d](/filings/0000950170-25-022243.md) | [28.6 d](/filings/0000950170-24-123679.md) | [32.1 d](/filings/0001193125-26-071441.md) | [25.4 d](/filings/0001193125-25-269546.md) | [45.5 d](/filings/0001193125-26-071441.md) | [23.9 d](/filings/0001193125-25-269546.md) | [46.8 d](/filings/0001193125-26-071441.md) |
| Dividends paid | $m | [42.3 d](/filings/0001564590-21-056408.md) | [42.3 d](/filings/0000950170-23-003619.md) | [44.5 d](/filings/0000950170-22-024470.md) | [44.4 d](/filings/0000950170-24-017647.md) | [46.6 d](/filings/0000950170-23-062044.md) | [46.4 d](/filings/0000950170-25-022243.md) | [48.6 d](/filings/0000950170-24-123679.md) | [48.5 d](/filings/0001193125-26-071441.md) | [50.5 d](/filings/0001193125-25-269546.md) | [50.5 d](/filings/0001193125-26-071441.md) | [52.3 d](/filings/0001193125-25-269546.md) | [52.3 d](/filings/0001193125-26-071441.md) |
| Share repurchases | $m | [0.0 d](/filings/0001564590-21-056408.md) | [0.0 d](/filings/0000950170-23-003619.md) | [8.5 d](/filings/0000950170-22-024470.md) | [0.0 d](/filings/0000950170-24-017647.md) | [18.1 d](/filings/0000950170-23-062044.md) | [0.0 d](/filings/0000950170-25-022243.md) | [4.6 d](/filings/0000950170-24-123679.md) | [14.9 d](/filings/0001193125-26-071441.md) | [0.0 d](/filings/0001193125-25-269546.md) | [0.0 d](/filings/0001193125-26-071441.md) | [0.0 d](/filings/0001193125-25-269546.md) | [0.0 d](/filings/0001193125-26-071441.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2020 (2020-10-03) | Q2 FY2021 (2021-07-17) | Q3 FY2021 (2021-10-09) | Q2 FY2022 (2022-07-16) | Q3 FY2022 (2022-10-08) | Q2 FY2023 (2023-07-15) | Q3 FY2023 (2023-10-07) | Q2 FY2024 (2024-07-13) | Q3 FY2024 (2024-10-05) | Q2 FY2025 (2025-07-12) | Q3 FY2025 (2025-10-04) | Q2 FY2026 (2026-07-18) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [212](/filings/0001564590-21-056408.md) | [213](/filings/0000950170-22-016871.md) | [213](/filings/0000950170-22-024470.md) | [213](/filings/0000950170-23-041331.md) | [213](/filings/0000950170-23-062044.md) | [213](/filings/0000950170-24-097806.md) | [212](/filings/0000950170-24-123679.md) | [212](/filings/0001193125-25-181262.md) | [212](/filings/0001193125-25-269546.md) | [212](/filings/0001193125-26-359192.md) | [212](/filings/0001193125-25-269546.md) | [212](/filings/0001193125-26-359192.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 212,057,418 at 2026-08-14, from the cover of the [10-Q filed 2026-08-20](/filings/0001193125-26-359192.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.